Jefferies Hosts KOL Positive Call on Sage Therapeutics (SAGE) SAGE-217 for Major Depression
Tweet Send to a Friend
Jefferies analyst Andrew Tsai reiterated a Buy rating and $100.00 price target on Sage Therapeutics (NASDAQ: SAGE) after hosting a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
